First Citizens Bank & Trust’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$522K Buy
2,753
+560
+26% +$105K 0.01% 457
2026
Q1
$433K Sell
2,193
-4
-0.2% -$771 0.01% 465
2025
Q4
$404K Buy
+2,197
New +$385K 0.01% 483

Other funds holding AZN

First Citizens Bank & Trust's AZN Position: Q2 2026 in Review

First Citizens Bank & Trust increased its AstraZeneca (AZN) stake by 26% in Q2 2026, buying an estimated $105K and bringing the position to 2,753 shares worth $522K. The position accounts for 0.01% of the portfolio, ranked #457.

First Citizens Bank & Trust first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • First Citizens Bank & Trust held 2,753 shares of AstraZeneca worth $522K as of Q2 2026.
  • First Citizens Bank & Trust bought 560 AstraZeneca shares in Q2 2026, an estimated $105K.
  • AstraZeneca made up 0.01% of First Citizens Bank & Trust's portfolio in Q2 2026, its #457 holding.
  • First Citizens Bank & Trust first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.